Nigeria has one of the lowest tuberculosis (TB) case detection rates in the world, with only 24% of cases being reported to the National TB and Leprosy Control Program. Breakthrough ACTION learned that patent and proprietary medicine vendors (PPMVs) are often the first points of contact in clients’ long treatment journeys due to proximity and low cost. One of the solutions being implemented in Nigeria is a simplified referral process where clients are referred by PPMVs for TB testing at a health facility. PPMVs keep ready-to-use referral slips attached to their calculators or calendar, two items that are constantly in use by PPMVs. The referral slips do not have to be filled out and do not require record-keeping. This Nigeria Tuberculosis Spotlight provides an overview of how Breakthrough ACTION applied the SBC Flow Chart to develop these solutions.
Web Policies | Sitemap | Contact Us
This website is made possible by the support of the American people through the United States Agency for International Development (USAID). The Breakthrough awards are supported by USAID’s Office of Population and Reproductive Health, Bureau for Global Health, under Cooperative Agreements: #AID-OAA-A-17-00017 and #AID-OAA-A-17-00018. Breakthrough ACTION is based at the Johns Hopkins Bloomberg School of Public Health’s Center for Communication Programs. Breakthrough RESEARCH is based at Population Council. The contents of this website are the sole responsibility of Breakthrough ACTION and Breakthrough RESEARCH. The information provided on this website is not official U.S. Government information and does not necessarily represent the views or positions of USAID, the United States Government, Johns Hopkins University, or Population Council.
© Johns Hopkins University. All rights reserved.
